As of Dec 15
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 115.00, with a high estimate of 140.00 and a low estimate of 82.00. The median estimate represents a +39.44% increase from the last price of 82.47.
The current consensus among 4 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.